P3 Health Earnings Estimate

PIII Stock  USD 2.14  0.13  6.47%   
The next projected EPS of P3 Health is estimated to be -7.82 with future projections ranging from a low of -7.8225 to a high of -7.8175. P3 Health's most recent 12-month trailing earnings per share (EPS TTM) is at -57.16. Please be aware that the consensus of earnings estimates for P3 Health Partners is based on EPS before non-recurring items and includes expenses related to employee stock options.
 
Covid
 
Interest Hikes
P3 Health is projected to generate -7.82 in earnings per share on the 31st of December 2025. P3 Health earnings estimates show analyst consensus about projected P3 Health Partners EPS (Earning Per Share). It derives the highest and the lowest estimates based on P3 Health's historical volatility. Many public companies, such as P3 Health, manage the perception of their earnings on a regular basis to make sure that analyst estimates are accurate. Future earnings calculations are also an essential input when attempting to value a firm.

P3 Health Revenue Breakdown by Earning Segment

By analyzing P3 Health's earnings estimates, investors can diagnose different trends across P3 Health's analyst sentiment over time as well as compare current estimates against different timeframes. The P3 Health's current Gross Profit is estimated to increase to about 1.8 B, while Pretax Profit Margin is projected to decrease to (0.25). Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in P3 Health Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.

P3 Health Earnings Estimation Breakdown

The calculation of P3 Health's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of P3 Health is estimated to be -7.82 with the future projection ranging from a low of -7.8225 to a high of -7.8175. Please be aware that this consensus of annual earnings estimates for P3 Health Partners is based on EPS before non-recurring items and includes expenses related to employee stock options.
Last Reported EPS
-9.67
-7.82
Lowest
Expected EPS
-7.82
-7.82
Highest

P3 Health Earnings Projection Consensus

Suppose the current estimates of P3 Health's value are higher than the current market price of the P3 Health stock. In this case, investors may conclude that P3 Health is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and P3 Health's stock will quickly adjusts to the new information provided by the consensus estimate.
Number of AnalystsHistorical AccuracyLast Reported EPSEstimated EPS for 31st of December 2025Current EPS (TTM)
238.21%
-9.67
-7.82
-57.16

P3 Health Earnings per Share Projection vs Actual

Actual Earning per Share of P3 Health refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering P3 Health Partners predict the company's earnings will be in the future. The higher the earnings per share of P3 Health, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.

P3 Health Estimated Months Earnings per Share

For an investor who is primarily interested in generating an income out of investing in entities such as P3 Health, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of P3 Health should always be considered in relation to other companies to make a more educated investment decision.

PIII Quarterly Analyst Estimates and Surprise Metrics

Earnings surprises can significantly impact P3 Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2025-11-13
2025-09-30-0.092-9.67-9.57810410 
2025-08-14
2025-06-30-0.11-6.23-6.125563 
2025-05-06
2025-03-31-7.915-6.281.63520 
2025-03-26
2024-12-31-0.11-0.36-0.25227 
2024-11-12
2024-09-30-0.04-0.29-0.25625 
2024-08-07
2024-06-30-0.05-0.09-0.0480 
2024-05-08
2024-03-31-0.11-0.16-0.0545 
2024-03-28
2023-12-31-0.11-0.22-0.11100 
2023-11-08
2023-09-30-0.22-0.120.145 
2023-08-07
2023-06-30-0.13-0.090.0430 
2023-05-10
2023-03-31-0.67-0.220.4567 
2023-03-31
2022-12-31-0.91-2.26-1.35148 
2022-11-14
2022-09-30-0.46-0.270.1941 
2022-08-31
2022-06-30-0.23-0.210.02
2022-04-25
2022-03-31-0.36-0.360.0
2022-01-07
2021-12-31-0.24-0.050.1979 
2021-12-09
2021-09-30-0.45-0.130.3271 
2021-09-01
2021-06-30-0.33-0.330.0
2021-05-25
2021-03-3100.120.12

About P3 Health Earnings Estimate

The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of P3 Health earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current P3 Health estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as P3 Health fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.
Last ReportedProjected for Next Year
Retained Earnings-452.9 M-430.2 M
Earnings Yield(4.78)(4.54)
Price Earnings Ratio(0.22)(0.23)

Currently Active Assets on Macroaxis

When determining whether P3 Health Partners is a strong investment it is important to analyze P3 Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact P3 Health's future performance. For an informed investment choice regarding PIII Stock, refer to the following important reports:
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in P3 Health Partners. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Is there potential for Health Care Equipment & Supplies market expansion? Will PIII introduce new products? Factors like these will boost the valuation of P3 Health. Anticipated expansion of PIII directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about P3 Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(57.16)
Revenue Per Share
442.863
Quarterly Revenue Growth
(0.05)
Return On Assets
(0.21)
Return On Equity
(2.03)
P3 Health Partners's market price often diverges from its book value, the accounting figure shown on PIII's balance sheet. Smart investors calculate P3 Health's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Since P3 Health's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
It's important to distinguish between P3 Health's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding P3 Health should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. However, P3 Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.